Moderate to Severe Secondary Hyperparathyroidism
1 clinical trials · Condition
◉ Watch Moderate to Severe Secondary Hyperparathyroidism
| Record | Firm | Date |
|---|---|---|
| A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients (NCT01506947) | AbbVie (prior sponsor, Abbott) | 2012-05-10 |
Track Moderate to Severe Secondary Hyperparathyroidism automatically
Every clearance here is in the API, with alerts when new ones post.